TRCT
BTAL icon

Tower Research Capital (TRC)’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Tower Research Capital (TRC)’s Portfolio BTAL Stock Details BTAL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Buy
+90
New +$1.09K ﹤0.01% 4909
2025
Q2 		– Sell
-480
Closed -$10K – 5274
2025
Q1 		$10K Buy
+480
New +$9.1K ﹤0.01% 3692
2013
Q4 		– Sell
-200
Closed -$4K – 4473
2013
Q3 		$4K Buy
+200
New +$4.02K ﹤0.01% 3773

Other funds holding BTAL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
CCA
Carrera Capital Advisors Troy, Michigan $675M AUM 17.92% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
AWM
AE Wealth Management Topeka, Kansas $21.5B AUM 26.98% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return

Tower Research Capital (TRC)'s BTAL Position: Q2 2026 in Review

Tower Research Capital (TRC) opened a new position in AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2026: 90 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #4909 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in BTAL as recently as Q1 2025.

Tower Research Capital (TRC) first reported a position in BTAL in Q3 2013 and has held it in 3 quarters since. The position peaked at $10K in Q1 2025. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

  • Tower Research Capital (TRC) held 90 shares of AGF US Market Neutral Anti-Beta Fund worth $1K as of Q2 2026.
  • AGF US Market Neutral Anti-Beta Fund was a new Tower Research Capital (TRC) position in Q2 2026.
  • AGF US Market Neutral Anti-Beta Fund made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4909 holding.
  • Tower Research Capital (TRC) first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2013 and has held it in 3 quarters since.
  • Tower Research Capital (TRC)'s AGF US Market Neutral Anti-Beta Fund position peaked at $10K in Q1 2025.
  • 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.